BIOMAT Database Logo BIOMAT Database Logo

Specificity and sensitivity of anti-HTLV-III/LAV determinations with a recombinant antigen competitive ELISA. 1986

K O Habermehl, and B Zorr, and F Deinhardt, and L Gürtler, and M A Koch, and G Maass, and W Höpken, and K W Knocke

UI MeSH Term Description Entries
D007158 Immunologic Techniques Techniques used to demonstrate or measure an immune response, and to identify or measure antigens using antibodies. Antibody Dissociation,Immunologic Technic,Immunologic Technics,Immunologic Technique,Immunological Technics,Immunological Techniques,Technic, Immunologic,Technics, Immunologic,Technique, Immunologic,Techniques, Immunologic,Antibody Dissociations,Dissociation, Antibody,Dissociations, Antibody,Immunological Technic,Immunological Technique,Technic, Immunological,Technics, Immunological,Technique, Immunological,Techniques, Immunological
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated

Related Publications

K O Habermehl, and B Zorr, and F Deinhardt, and L Gürtler, and M A Koch, and G Maass, and W Höpken, and K W Knocke
Sensitivity and specificity of commercial ELISA kits for screening anti-LAV/HTLV III.
January 1987, Journal of virological methods,
K O Habermehl, and B Zorr, and F Deinhardt, and L Gürtler, and M A Koch, and G Maass, and W Höpken, and K W Knocke
[Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)].
January 1986, Rivista di emoterapia ed immunoematologia,
K O Habermehl, and B Zorr, and F Deinhardt, and L Gürtler, and M A Koch, and G Maass, and W Höpken, and K W Knocke
Anti-HTLV-III screening specificity and sensitivity.
May 1986, Lancet (London, England),
K O Habermehl, and B Zorr, and F Deinhardt, and L Gürtler, and M A Koch, and G Maass, and W Höpken, and K W Knocke
[Value of ELISA in the diagnosis of HTLV-III-LAV infection. Specificity of kits].
December 1986, Presse medicale (Paris, France : 1983),
K O Habermehl, and B Zorr, and F Deinhardt, and L Gürtler, and M A Koch, and G Maass, and W Höpken, and K W Knocke
Screening for anti-HTLV-III/LAV antibody in high-risk subjects: sensitivity and specificity of commercial tests.
January 1987, International archives of allergy and applied immunology,
K O Habermehl, and B Zorr, and F Deinhardt, and L Gürtler, and M A Koch, and G Maass, and W Höpken, and K W Knocke
Evaluation of eight ELISA kits for the detection of anti-LAV/HTLV-III antibodies.
May 1986, Lancet (London, England),
K O Habermehl, and B Zorr, and F Deinhardt, and L Gürtler, and M A Koch, and G Maass, and W Höpken, and K W Knocke
Anti-HTLV-III/LAV in pooled sera.
February 1987, Clinical chemistry,
K O Habermehl, and B Zorr, and F Deinhardt, and L Gürtler, and M A Koch, and G Maass, and W Höpken, and K W Knocke
[In vitro diagnosis and anti-LAV/HTLV III].
December 1985, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie,
K O Habermehl, and B Zorr, and F Deinhardt, and L Gürtler, and M A Koch, and G Maass, and W Höpken, and K W Knocke
[Anti-HTLV-III/Lav antibodies, clinical symptoms and immunological determinations in hemophilia patients in Buenos Aires].
January 1985, Medicina,
K O Habermehl, and B Zorr, and F Deinhardt, and L Gürtler, and M A Koch, and G Maass, and W Höpken, and K W Knocke
[Anti-HTLV-III/LAV antibodies in hematology reactives].
January 1986, Sangre,
Copied contents to your clipboard!